Skip to content
Search
Login
About Us
News
Webinars & Events
Resources
Contact Us
About Us
News
Webinars & Events
Resources
Contact Us
Search
Login
About Us
News
Webinars & Events
Resources
Contact Us
About Us
News
Webinars & Events
Resources
Contact Us
News
Search by Keyword
Filter by Category
Any
Artificial Intelligence (AI)
CHC News
CHC Webinars
Courts/First Amendment
Data Privacy
Drug Pricing
DTC Advertising
General
Legislative
Off-label Promotion
Point of Care
Regulatory/FDA
Uncategorized
Washington Focus
Filter by Tags
Any
#StopHateForProfit
2.0
2014
2014 DTC spending
2014 election
2015
2016
2020 budget
2020 election
21st Century Cures
21st Century Cures Act
2253
4A's
510(k)
a
AAAA
AAF
AAFP
Aaron Kesselheim
AARP
AbelsonTaylor
abortion
ACA
ACA enrollment
ACA marketplace
academic detailing
accelerated approval
accelerated approval disclosure
accelerated drug approval
Acceleron
ACCME
AcelRx
Aclaris
ACNU
ACRE
Acting FDA Commissioner
Ad Age
ad agency
ad coa
ad coalition
ad disclosures
ad networks
ad tax
ad tax deduction
Addictive Algorithms
additional condition for nonprescription use
Addyi
Adequate Directions for Use
adequate provision
Administrative Procedures Act
adolescent
ADPPA
aducanumab
Aduhelm
AdvaMed
adverse event
advertising
Advertising Coalition
advertising regulations
advertising ta
advertising tax
advertising tax deduction
advisory committee
advisory committees
advocacy
Affordable Care Act
AG's Office
AgencyIQ
AI
Al Franken
Alan Bennett
Alex Azar
Alison Pepper
Alkindi Sprinkle
Alliance for a Stronger FDA
Althera
Alzheimer's
AMA
AMA ban
AMA CEJA June 2009
Amarin
Amazon
American advertising federation
American association of advertsing agencies
American Medical Association
Amgen
Amherst Pharmaceuticals
amicus brief
AMM
AMWA
Amy Abernethy
Amy Klobuchar
ANA
Angel
Angus King
animated banner
animation
Anna Eshoo
Another Tag
Anthiny Fauci
anti-kickback
antibiotic
antifungal
antimicrobial
antiviral
antivirals
APLB
appeal
appropriations
approval rate
APRA
arizona
ARPA-H
artificial intelligence
asaf evenhaim
ASCEND
ASCO
association of national advertisers
AstraZeneca
Avastin
Azurity
b
bad ad program
Bagger
ban on music
Bausch
Bayer AG
beh
behavioral advertising
bennet
bennett
Biden
Biden administration
Biden budget
Bill Gates
BIO
Biogen
Biohaven
biological license application
BioPharma
Biosimilar User Fee Act
biosimilars
BLA
black box warning
Blue Dog
BMJ
booth display
boxed warning
breakthrough drugs
brief summary
Brill
Bristol-Myers Squibb
broadcast drug ads
brochure claims
bronshtein
Brooks-LaSure
Bruce Grant
Bruce Haynes
BsUFA
Buccino
Budesonide
budget
Build Back Better Act
burden
Burgess
Burr
Business Insider
c
Califf
Califf confirmation
California
California Ballot Initiative
California Consumer Privacy Act
California Consumer Protection Act
California Privacy Rights Act
Cambridge Analytica
cancer
cancer claims. Thermography Business Package
cancer drugs
Cancer Support Community
Capitol Hill
careers in healthcare communication
Carolyn Maloney
caronia
Catalyst Healthcare Consulting
Catherine Gray
Cathy McMorris Rodgers
CBER
CBER approvals
CBO
CCPA
CDC
CDER
CDER approvals
CDER priorities
CDRH
CEI
CEJA
Celator
celebrity endorsement
Celgene
cellphone tracing
Center for Communication Compliance
Center for Drug Evaluation and Research
Center for Drug Research and Evaluation
Centers for Medicare & Medicaid Services
CER
certified medical education
Charles Grassley
chc
CHC 11.2018 Post Election Conference
CHC comments
CHC guidance
CHC meeting
CHC News
CHC Rising Leaders Conference
CHC Webinar
Chevron doctrine
child data privacy
Chris Christie
Cipher
CISA
Citizen Petition
Claire McCaskill
clinical data
clinical guidelines
clinical trial reporting
clinical trials
clinical trials. ClinicalTrials.gov
Clinton
close-hold embargo
CME
CME exemption
CMPI
CMS
CMS final rule
CMS proposed rule
CO
Coal
coalition
coalition for healthcare communication
Coalition for Healthcare Communication conference
Coalition for Healthcare Communication mission
Coalition for Healthcare Communication webinar
Coalition for Healthcare Communications
Coalition of Healthcare Communication
Coalition Speaks
Cobra venom
code of ethics
COI
collaboration
Collegium
Colorado
Colorado Privacy Act
comment
comments on CME
commercial data
commercial support
commitment letter
communications
comparative effectiveness
competition
compliance
Compliance tips
Compliancy Group
Computer & Communications Industry Association
conference
Conference Material
confirmation
confirmatory trials
conflict of interest
Congress
consumer drug information
consumer input
consumer privacy
consumer protection
consumers
contact tracing
context
Continuing Resolution
contracting
Contrave
Contrave. Nalpropion
ConZip
cooke
CooperSurgical
Coronavirus
Corporate backing of medical research
counterfeiting
COVID-
COVID-19
COVID-19 advisory board
COVID-19 cases
COVID-19 therapeutics
COVID-19 vaccine
CPGs
CPRA
credible
credible health information
CRPB
CSL Behring
CTDPA
Cures 2.0
CytoDyn
DAA
Dale Cooke
Dale Taylor
Dan Jaffe
data brokers
data privacy
data privacy legislation
data security
Davidson
DC Circuit Court of Appeals
DDMAC
debate over physicians paid to speak at events
deceptive claims
deceptive promotion
DeGette
denials
Department of Health and Human Services
deregulation. data privacy
detailing
device approval. device clearance
device claims
DIA
Dick Durbin
Dick O'Brien
dietary supplement claims
dietary supplements
digital ad
digital ad tax
digital advertising
digital health
digital health coalition
digital marketing
Digital Payment Apps
digital platforms
Digitas Health
direct-to-consumer
direct-to-patient purchasing plaforms
disclosures
disease awareness
disease awareness ads
disinformation
display ads
diversity
diversity data
Division of Promotion Policy Research and Operations
DMA
do not track
doctors
DOJ
Donald Trump
Donna Murphy
Doral
DPPRO
Dr. Brett Giroir
Dr. Fabio Almeida
Dr. Janet Woodcock
Dr. Ned Sharpless
Dr. Robert Califf
Dr. Scott Gottlieb
Dr. Stephen Hahn
draft guidance
drug advertising
drug approval
drug approvals
drug benefits
drug characteristics
drug cost
drug costs
drug facts
drug importation
drug industry
drug information
drug list price
drug manufacturing. Kodak
drug marketing
drug name placement
drug pri
drug price dislosure
drug price transparency
Drug prices
drug prices in DTC ads
drug pricing
drug pricing blueprint
drug pricing legislation
drug pricing reform
drug pricing reform. Medicare negotiating drug prices
drug pricing. ad tax deduction
drug pricing. Inflation Reduction Act
drug promotion
drug promotion. television ad
drug review
drug risks
drug spending
drug value
Drugs@FDA Express
Drugwonks
Dsuvia
DTC
DTC ads
DTC advertising
DTC advertising
DTC advertising ban
DTC advertising costs
DTC advertising. accelerated approval
DTC benefits
DTC broadcast ads
DTC consumer survey
DTC drug ads
DTC Research
DTC Rx Advertising
DTC selling platforms
DTC spending
DTC Tool Kit
DTC. multiple indications
DTCA
Duke-Margolis
Duobrii
Durbin. drug pricing
early voting
EC
eCTD
Ed Silverman
education
educational events
efficacy
efficacy claims
efficacy information
EHR
eLearning
election
election day
elections
electronic health record
electronic submission
Eli Lilly
Elizabeth Warren
Elizabeth Warren. Bill Cassidy
email
email claims
embargo
emergency relief
Emgality
Employee Data
EMRs
end-of-life care
Endorsement Guide
Energy & Commerce
enforcement
enforcement letter
enriched trials
enrichment
Eric Densmore
Eskata
estimates
EstroGel
ethnicity
Eton Pharmaceuticals
EU
EUA
Evan Jenkins
evans
executive order
exemption. class II device
exhibit booth
Exparel
experimental treatment
Facebook
Facebook ad boycott
faculty thought leaders
Fake news
false and misleading
False claims
false news
false. misleading
FAQs
FAR
FAR Council
fast track
FCC
FDA
FDA Advisory Committee
FDA approval
FDA approval process
FDA Approvals
FDA approvals. CDER
FDA Budget
FDA certified
FDA Commissioner
FDA Commissioner confirmation
FDA Commissioner nominee
FDA Commissioner Stephen Hahn
FDA commissioners
FDA disclosure study
FDA Draft Guidance
FDA drug approvals
FDA DTC research
FDA enforcement
FDA FDA user fees
FDA final guidances
FDA Form 2253
fda funding
FDA guidance
FDA hearing
FDA inspections
FDA mobile app. Drugs@FDA
FDA off-label hearing
FDA press release
FDA priorities
FDA reform
FDA registered
FDA regulations
FDA research
FDA reviewers
FDA settlement
FDA social media
FDA staffing
FDA studies
FDA study
FDA survey
FDA/Industry collaboration
FDAAA
federal budget
federal contracting
federal device ban
federal legislation
federal preemption
federal privacy legislation
federal privacy legislation. state privacy legislation
Federal Trade Commission
Fifth Amendment
final rule
First A
First Amendment
FleishmanHillard
food as medicine
foreign inspections
formulary
Frank Pallone
Franken
fraud
fraud alert
free
free speech
friede
FTC
FY 2021 Budget
FY 2023 budget
Galt
Gavin Newsom
GDPR
GDUFA
gender
general
generics
Giegerich
gift ban
gifts to physicians
GLOBE
Goldberg
Good Rx
Google
Gottlieb resignation
Gov. Jared Polis
Gov. Larry Hogan
government contracting
GrowthLab
GSK
guidance
Gvoke
H.R. 5539
hackers
Hamburg
Harris Poll
Harry Sweeney
Harvard
hatch
HB 2961
HB 4005
HB 732
HBRN
HCEI
HCP
HCP ads
HCPs
Health Affairs
Health Breaches
health care economic information
health data
health policy
Health Research Agency
health tracking poll
healthcare
Healthcare communication
healthcare communications
healthcare communicators
healthcare costs
healthcare economic information
healthcare marketers
healthcare marketing
healthcare policy
healthcare professionals
healthcare reform
HELP Committee
HHS
HHS budget
HHS Grassley
HHS OCR
HHS regulations
HHS Secretary
HIPAA
HIPAA adjacent
hiring freeze
HIV
Hogan
Hospira
hospitals. covid
House
House Appropriations
House bills
House Commerce Committee
House drug pricing bill
House Energy and Commerce Committee
House Health Subcommittee
House Subcommittee on Health
HR 2026
HR 293
HRA
Huftalen
Hunt
hydroxychloroquine
hyperlinks
Idelvion
Ilyssa Levins
importation
IMS v. Sorrell
incentives
IND
IND promotion
indications for use
individual mandate
industry funding
Industry Person of the Year
industry prescriber collaboration
industry principles
Inflation Reduction Act
influencer
influencers
infrasctucture
innovation
Instagram
insulin
intended use
interim rule
International Pricing Index
Internet
Internet Association
interstate commerce
investigational new drug
IOM
IPI
IQVIA
IRA
Irwin Gerson
ISI
ISMPP
J&J
Jack Angel
Jack Resneck
Jahn Kamp
James Czaban
James Potter
Janet Woodcock
Jay Carter
JD Cassidy
Jeanne Shaheen
Jeffrey Francer
Jeffrey Shuren
Jeffrey Zients
Jenkins
Jesse Milan Jr.
Jim Czaban
Jim Davidson
Jim Potter
Joe Biden
Joe Manchin
John Barrasso
John Kamp
John Swift
Johnson & Johnson
Joint Position Statement on Predatory Publishing
Jon Bigelow
Jon Bigelow pharma
Jon Bigelow. Kate Rawson
Jon Bigelowpredatory publishing
Joshua Sharfstein
journal abstracts
journal articles
journal reprints
Judge Reed O'Connor
Justin Freid
Kaiser
Kaiser poll
kamo
kamp
Kamp.PhRMA
Kamp.Pitts
Karsten Risch
Kate Rawson
Kate Rawson. CHC
Kate Rawson. Jon Bigelow
Kathryn Aiken
Kathryn Aikin
Katie David
Katie Gray
Kay Holcombe
Kellie Combs
Kenneth Berkowitz
Keytruda
keywords
kids and teens
kleinke
Kowa
Kyrsten Sinema
l
labeling
Labor
Laura Schoen
lawsuit
Lee Peeler
legis
legislation
LEO Pharma
leronlimab
Lesley Fair
letter from medical groups
Lilly
Limited risk disclosure
list price
list prices
litigation
Livalo
Long
Lori Reilly
Lupus Foundation
MA plans
Magna Pharmaceuticals
MAHF
mail-in voting
Maine
major statement
Makena
mandated drug prices
MAO
mark shields
marketing
Marketing Architects
marketing costs
marketing development. training
marketing pitch
marketing tax
marketing tax deduction
Martin Makary
Maryland
Maryland ad tax
Massachusetts
MassBIO
Matt Giegerich
McCaskill
McCaughan
MDUFA
meals
meals to physicians
Medical Advertising Hall of Fame. Jon Bigelow
medical communication
medical communications
medical device
Medical information
medical journals
medical marketing
medical textbooks
Medicare
Medicare Advantage
Medicare coverage
Medicare for All
Medicare negotiations
Medicare Part B
Medicare Part D
Medicare reform
medication adherence
medicine
MedPage Today
Medscape
member meeting
Merck
merger
Metuchen
MFN tariffs
Michael McCaughan
Michael Parenti
microbiome
midterms
Migliarese
Mike Kapetanovic
Mike McCaughan
Minnesota
misbranding
misinformation
misinformation sites
misleading
misleading claims
mit spears
MIWG
MM&M
MN
MoA
mobile apps
mobile health
mobile medical applications
modest meals
Mollie Rosen
most favored nation
most favored nation tariffs
Murray
music ban
name placement
name prominence
name size
NAMI
Nancy Bradish Myers
Nancy Myers
Nancy Pelosi
National Academies
National Psoriasis Foundation
national security tariffs
native advertising
navigating Washington
NBER
NCCN
NCD
NCSC
NDHI
Ned Sharpless
NEJM
Nephron
NetChoice
neural data
Nevada
new drug
new drugs
New Hampshire
New Jersey
New York
New York Times
News
Newsguard
Newsweek
NH
Nick Colucci
NIH
NJ gift ban
NJ payment caps
NMEs
nomination
non-CME
non-compete
nonprescription drugs
Novartis
novel drug approvals
novel drugs
Novo Nordisk
NPRM
NRLB
nurse practitioners.physician assistants
Nurtec ODT
Nutra Pharma
NY
Nyloxin
Obama
Obamacare
off-label
off-label code of ethics
off-label communication
off-label legislation
off-label litigation
off-label use
Office of Inspector General
Office of Oncologic Diseases
Office of Prescription Drug Promotion
ogilvy
OIG
Oklahoma
OMB
omicron
omission of material fact
omission of risk
Omission of Risk Information
omnibus bill
oncology
oncology drugs
online
online ads
online advertising
online data privacy
online promotion
OOD
OOP
Opana ER
Opdivo
OPDP
OPDP Director
OPDP enforcement
OPDP enforcement. Warning Letter
OPDP Guidance
OPDP press release
OPDP research
OPDP research methods
OPDP research studies
OPDP study
OPDP Untitled Letter
OPDP. FDA Enforcement
OPDP. OPDP research
Open Payments
openpayments
opinion of pharma
opioid
opioid abuse
opioid crisis
opioids
oregon
Oregon House Committee on Health Care
Orexigen
OTC
OTC monograph
OTC regulation
OTC user fees
outcomes research
Outlook
Pacira
Pacira settlement
pain management
pain relief
Pallone
Pam Jenkins
pandemic
pandemic COVID-19
ParaGard
Paraguard
Part D rebates
Pasteur Act
Pat Toomey
patel
patent protection
patient
patient access
patient outcomes
patients
Patients for Affordable Drugs
Patrizia Cavazzoni
Patrizia Cavozzoni
pay for delay
payer communication
payer communicaton
payers
payments to physicians
payor communication
payors
PBMs
PCMA
PDUFA
PDUFA VI
PDUFA VII
personal health data
Peter Frishauf
peter kosmala
Peter Pitts
Pfizer
pharm-to-table
pharma
pharma advertising
pharma industry
pharma matters
pharma social media
pharma tariffs
pharma trouble
pharmaceutical
pharmaceuticals industry
pharmacoeconomics
Pharmalot
Pharmaphobia
PHI
Phoenix Molecular Imaging
PhRMA
PhRMA DTC Code
physician
physician interpretation of scientific info
physician perceptions
physicians
pines
piracy
pitts
policy
political landscape
political pressure
POLITICO
politics
poll
polling
Post-election Conference on Healthcare Policy
post-election webinar
Postmarket studies
postmarketing submissions
postpone
Pourhassan
PR materials
PRAs
Precedex
preliminary injunction
premarket notification
PrEP
presc
prescriber data
prescription data
prescription drug advertising
prescription drug costs
prescription drug names
prescription drug price negotiations
prescription drug user fee act
Prescription Drug User Fee Act. BsUFA
prescription drug user fees
Prescription Drug Value
presentation of risk information
President Joe Biden
President Trump
President Trump. Executive Orders
President-elect Joe Biden
press release
preventive health
preventive services
price caps
price disclosures in DTC ads
price transparency
primary endpoint
Principles for Privacy Legislation
print ads
prior authorization
privacy
Privacy for America
privacy legislation
programmatic advertising
prominence
promoting unapproved drug
promotion
promotional claims
promotional labeling
promotional medical education
promotional regulation. Ned Sharpless
promotional research
Prop 24
Propel Media
proprietary name
ProPublica
Public Citizen
public health
public opinion
publication support
Publicis Health
publuc trust
PURELL
Qsymia
quantitative
race
rachel thomas
radio
radio ad
RAND
rare disease marketing
rare diseases
rates of FDA approval
Rawson
Rawson webinar
Real-world data
real-world evidence
rebates
regulation
Regulatory Compliance University
reimbursement
rein
remote interactive evaluations
remoxy
reprints
research
resistance
Rhode Island
RI
Richard Durbin
Richard Pazdur
Ridgeback Therapeutics
Rising Leader Presentation
Rising Leaders 2017
Rising Leaders 2019
rising leaders conference
Rising Leaders Conference 2018
risk disclosures
Risk Information
risk presentation
risk-based monitoring
Robert Califf
Robocall
Robotext
Rochelle Walensky
Rockefeller
Rodgers
Roe v. Wade
Romney
Ron Wyden
Rosa DeLauro
Roszet
RPM Report
rulemaking
Ruth Bader Ginsburg
RWD
RWE
rx
rx data
Rx pricing
rxdata
Saatchi & Saatchi Wellness
safe harbor
sales aids
sales representtive
Samp
sanofi
scams
science
Scientific American
Scott Gottlieb
Sean Boyd
second circuit
SEM
Sen. Chris Coons
Senak
Senate
Senate Bill
senate commerce committee
Senate confirmation
Senate Finance Committee
Senate HELP Committee
sensitive health data
sensitive information
Service to Industry Award
severability
Sharon Callahan
side effect
skinny plans
snake venom
social media
social media advertising
sorrell
speaker payments
speaker program
speaker programs
speakers bureaus
spears
special fraud alert
specialty groups
spending bill amendment
sponsored link
sponsored tweets
Spriaso LLC
Sprout
staff paper
Stark
STAT
state advertising laws
state laws
state legislation
state regulation
states
stealth ads
Stendra
Stephen Hahn
stephen kline
Stephen Ubl
Steve Ubl
Steven Ubl
stockpile
streaming
Stu Ingis
Stuart Ingis
study source
subscription mode;
Sullivan
sun
sunscreen
SUNSET final rule
sunshine
sunshine act
superiority claims
Supreme C
Supreme Court
surprise medical bills
surrogate endpoint
Susman
Tag
targeted mechanism of action
targeted MoA
tariffs
tavenner
tax bill
tax legislation
tax reform
tax revenue
taxation
teens
telehealth
Telemarketing
telemedicine
Telephone Consumer Protection Act
television
television advertising
testimony
textbooks
the advertising coalition
The AIDS Institute
TikTok
time pressure
Time to Vote
Time's Up Advertising
tobacco
Tom Abrams
Tom Stossel
Total Thermal Imaging
totality of the evidence
tradeoffs
transfers of value
transparency
Treatment Action Group
Trulicity
Trump
Trump administration
Trump and advertising
Trump drug pricing
Trump drug pricing. drug pricing
TrumpRx
Trust
TV ad
tv ads
TV drug ads
Twitter
U.S. Chamber of Commerce
U.S. Court of Appeals for the District of Columbia
U.S. Court of Appeals for the Fifth Circuit
U.S. District Court for the District of Columbia
U.S. District Court for the Northern District of Texas
U.S. Supreme Court
Ubl
unapproved drug
unapproved drugs
unapproved use
United Kingdom
United-Guardian Inc.
UnitedHealthcare
Untitled Letter
untitled letters
Upton
user fee legislation
user fee reauthorization
user fees
user fees. prescription drug user fees
vaccine
vaccines
value of marketing
value of medicine
Vanda Phramaceuticals
vaping
variant
Vermont
Vermont gift ban
Vertex
Vertical
veto
VHA
Violet Aldaia
VIVUS
voluntary agreements
voting
WAC
wall street journal
Warning Letter
warning letters
Warnng Letters
washington
Washington DC
Washington Post
Washington Privacy Act
Washngton DC
Wayne Pines
Ways and Means
web ads
Weber
webinar
webpage
webpages
website claims
websites
weight-loss claims
Wendy Blackburn. Pam Jenkins
werble
White House
White House appointment
White House budget
White House drug pricing
wholesale prices
withdrawal of SUNSET rule
WLF
Woodcock
Woolley
Workforce Mobility Act
Xarelto
Xatmep
Xavier Becerra
Xeris
YouTube
Zirkelback
Reset Filters
Reset Filters
11/12/2025
Shutdown Ending Deal Extends Medicare Telehealth
Learn More
11/06/2025
What Healthcare Marketers Need to Know about the Pharma Tariff or “MFN” Negotiations
Learn More
10/29/2025
CHC Earned Media (10-29-25 update)
Learn More
10/23/2025
Pharma Voluntary Tariff Waivers and the Advent of TrumpRx
Learn More
10/21/2025
What Pharma Can Teach Every Marketer About Risk, Regulation and Trust
Learn More
09/17/2025
Summary, Analysis and Recommendations on the Administration’s Announcements to Limit Rx Ads
Learn More
06/30/2025
Health Data Privacy Moves Into Focus
Learn More
06/16/2025
Fact Sheet on the Benefits of Healthcare Communication & Marketing
Learn More
05/14/2025
Impact of “Most Favored Nation” Rx Price Control Executive Order
Learn More
